What To Expect?
KYBELLA® (deoxycholic acid) injection is the first and only FDA approved an injectable treatment that contours and improves the appearance of submental fullness, sometimes referred to as “double chin”. When injected into the fat beneath your chin, KYBELLA® causes the destruction of fat cells. Once destroyed, those cells cannot store or accumulate fat.
What Is KYBELLA®?
How Does KYBELLA® Work?
The active ingredient in KYBELLA® is deoxycholic acid, a naturally-occurring molecule in the body that aids in the breakdown and absorption of dietary fat. When injected into the fat beneath your chin, KYBELLA® cases the destruction of fat cells. Once destroyed, those cells cannot store or accumulate fat.
Is KYBELLA® Right For Me?
If you’re bothered by submental fullness or double chin, KYBELLA® may be right for you. KYBELLA® treats submental fullness caused by fat cells, it does not treat loose skin. A consultation is needed in order to determine if KYBELLA® is the right choice for you.
How Many People Have Been Treated With KYBELLA®?
KYBELLA® has been the focus of a global clinical development program involving over 20 clinical studies with more than 2,600 patients worldwide, of which over 1,600 have been treated with KYBELLA®.
Will I Experience Any Side Effects?
The safety profile of KYBELLA® is well characterized. The most common side effects are swelling, bruising, pain, numbness, redness and areas of hardness around the treatment area. Icing the treatment area for 15 minutes after the treatment is recommended to help minimize swelling.
How Many Treatments Will I Need?
You and your provider will customize your KYBELLA® treatment regimen, including how many treatments you need, based on your desired chin profile. Many patients experience visible results in 2 to 4 treatment sessions. During these sessions, your provider will administer KYBELLA® into the fat under your chin using multiple injections. Up to 6 treatment sessions may be administered spaced no less than one month apart.
In clinical studies, results for KYBELLA®-treated patients who had a ≥1-grade composite improvement were 8% (1 treatment), 28% (2 treatments), 43% (3 treatments), 55% (4 treatments), 66% (5 treatments) and 72% (6 treatments)
In clinical studies, results for KYBELLA®-treated patients who had a ≥2-grade composite improvement were 0% (1 treatment), .2% (2 treatments), .8% (3 treatments), 3.5% (4 treatments), 3.9% (5 treatments) and 15% (6 treatments)
59% of subjects in the clinical trials received all 6 treatments
How Long Will The Results Last?
When injected into the fat under your chin, KYBELLA® causes the destruction of fat cells. Once destroyed, those cells cannot store or accumulate fat. After the aesthetic response is achieved, retreatment with KYBELLA® is not expected.2
Who Should Not Receive KYBELLA®?
You should not receive KYBELLA® if you have an infection in the treatment area.